Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinoma. Neil AJ, Nkosi D, Yoon JY, Kolin DL, et al. Histopathology 2025;87:310-320.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neil AJ, Nkosi D, Yoon JY, Kolin DL, et al. Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinoma. Histopathology 2025;87:310-320.
PMID: 40162568